Clinical characteristics, effectiveness, safety, and predictors of PASI75/90 responses to IL-17 biologics in psoriasis involving special sites: a large real-world cohort study revealing treatment response heterogeneity
Overall, IL-17 inhibitors show substantial efficacy and a favorable safety profile for psoriasis in special sites, with treatment response variability influenced primarily by baseline clinical characteristics such as BMI and disease severity indices.
Authors
- Xiaohua Tao (ORCID: https://orcid.org/0000-0002-1698-0969)
- Xinglong Xiong
- Fengming Hu
- Lihua Zhang
- Yujie Lai
Institutions
- Nanchang University (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- Gannan Medical University (CN)
- Jiangxi Chest Hospital (CN)
- First Affiliated Hospital of Nanchang University (CN)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1080/09546634.2026.2633794
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00